Nachrichten zur Alexion Pharmaceuticals Inc. Aktie

Plenty More Upside To See In Alexion Pharmaceuticals In 2020

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Alexion Pharmaceuticals a Buy?

With a strong grip on its target markets and a promising pipeline, this company should continue to grow....…

Why the Earnings Surprise Streak Could Continue for Alexion (ALXN)

Alexion (ALXN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Price Over Earnings Overview: Alexion Pharmaceuticals

Alexion Pharmaceuticals bid up on PE chatter

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion Pharma: Völlig egal, ob der Mega-Merger kommt!

Zu den Topgewinnern an den US-Aktienmärkten zählt heute die Aktie des Biopharmakonzerns Alexion Pharmaceutical (WKN: 899527). Da stellt sich natürlich…

Alexion Plans to Raise 2020 Sales View, Buy Back $3B Shares

Alexion (ALXN) announces plans to increase its 2020 sales guidance by more than $200 million and buy back $3 billion…

Should you invest in Alibaba, Draftkings, Boeing, SunPower Corp, or Alexion Pharmaceuticals?

NEW YORK ,, Oct. 7, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…

Top Analyst Upgrades and Downgrades: Alexion, Amazon, Diageo, eBay, Etsy, Home Depot, MGIC, Netflix, Sirius XM, Vir Bio and More

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion Pharmaceuticals: More Potential Ahead Despite Upbeat Guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion Says Promising New Drugs Will Boost Growth

The company said Tuesday it plans to raise its full-year guidance by more than $200 million when it reports earnings…

Alexion Plans to Boost Revenue Guidance, Buy Back $3 Billion of Stock

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion Pharmaceuticals hikes FY20, FY25 revenue guidance

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexions stock rises after upbeat revenue outlook, plan to buy back at least $3 billion in stock through 2023

Shares of Alexion Pharmaceuticals Inc. rose 1.5% in premarket trading Tuesday, after the biopharmaceutical company said it expects to…

Alexion expects to return $3 bln to shareholders through 2023

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

ALEXION PHARMACEUTICALS, INC.: 8-K Report

8-K...…

Stocks This Week: Sell Short Alexion Pharmaceuticals And Mattel

This coming weak is likely to be bearish but is also likely to be the end of the September decline....…

Should you invest in Alexion Pharmaceuticals, Netflix, XPO Logistics, Square, or Tesla?

NEW YORK , Sept. 16, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for…

Alexion Pharma up 7% on rumored Biogen interest

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion & Caelum Begin Studies on CAEL-101 in AL Amyloidosis

Alexion (ALXN) and partner Caelum Biosciences begin phase III studies on CAEL-101 in AL amyloidosis....…

Fortress Bio and Alexion launch late-stage CAEL-101 study in AL amyloidosis

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Fortress Biotech Announces Initiation of Phase 3 Studies of CAEL-101 in AL Amyloidosis

- Caelum Biosciences, a company founded by Fortress, is collaborating with Alexion Pharmaceuticals on the studies...…

Alexion Pharmaceuticals (ALXN) Gains As Market Dips: What You Should Know

Alexion Pharmaceuticals (ALXN) closed at $112.97 in the latest trading session, marking a +1.3% move from the prior day....…

Acadia, Novocure & Alexion Stocks Are Out Of Favor, But Promising

Our indicative theme of Out Of Favor Healthcare Stocks is down by about -9% year-to-date versus the S&P 500 which…

Alexion (ALXN) Catches Eye: Stock Jumps 6.8%

Alexion (ALXN) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes....…

Alexion Stock Jumps Because Novartis’ PNH Drug Might Not Be a Threat

Novartis released data on a drug that competes with Alexion’s biggest sellers. J.P. Morgan analyst Cory Kasimov calls the results…

Alexion Pharmaceuticals: Good Growth But Out Of Favor

Alexion Pharmaceuticals stock hasnt moved much this year. But thats not new. Despite growing its EBITDA per share by nearly…

ALEXION PHARMACEUTICALS, INC.: 8-K Report

8-K...…

Top Analyst Upgrades and Downgrades: Alexion, Allscripts, Alphabet, Amazon, Apple, Baidu, Comcast, EA, Ford, Facebook and More

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Alexion Could Have the Most Upside of All Established Pharma & Biotech Stocks

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion Pharmaceuticals, Inc. (ALXN) CEO Ludwig Hantson on Q2 2020 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion Pharmaceuticals, Inc. 2020 Q2 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

ALEXION PHARMACEUTICALS, INC.: 10-Q Report

10-Q...…

ALEXION PHARMACEUTICALS, INC.: 8-K Report

8-K...…

Alexion Reports Second Quarter 2020 Results

BOSTON--(BUSINESS WIRE)--Alexion Reports Second Quarter 2020 Results...…

Alexion Pharmaceuticals Q2 2020 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Earnings Season Could Be Great for Alexion (ALXN)

Alexion (ALXN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Alexion, Novocure, ACADIA: Out Of Favor Health Care Stocks Poised For Gains

The performance of the healthcare sector has been mixed this year. While dental and surgery-related stocks have declined - as…

Inozyme buys ENPP1 deficiency program assets from Alexion

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion Needs to Ditch Its Acquisitions Strategy, Analyst Writes

SVB Leerink analyst Geoffrey Porges argues that the drugmaker’s acquisitions aren’t working, and that the whole capital allocation strategy needs…

Alexion Pharmaceuticals: Growth At A Reasonable Price (GARP)

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion Pharmaceuticals Agrees to $21.5 Million Settlement With SEC in Bribery Case

The company was accused of making improper payments to government officials in Turkey and Russia....…

Why the Earnings Surprise Streak Could Continue for Alexion (ALXN)

Alexion (ALXN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Alexion completes acquisition of Portola Pharma; SEC charges with FCPA violations

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alexion to pay $21 million to resolve SEC charges

Shares of Alexion Pharmaceuticals Inc. were up 0.1% in trading on Thursday after the Securities and Exchange Commission said…

ALEXION PHARMACEUTICALS, INC.: 8-K Report

FORM 8-K...…

SEC Charges Alexion Pharmaceuticals With FCPA Violations

Washington, D.C.--(Newsfile Corp. - July 2, 2020) - The Securities and Exchange Commission today announced that Boston-based pharmaceutical company Alexion…

Alexion Completes Acquisition of Portola

BOSTON--(BUSINESS WIRE)--Alexion Completes Acquisition of Portola...…

Shares of Apellis rise on clinical data for rare blood disease drug

Shares of Apellis Pharmaceuticals Inc. gained 5.1% in premarket trading on Friday after it shared details from a late-stage…

Alexion Pharmaceuticals: Patent Resolution Is Too Little Too Late

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…